Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine versus pregabalin for opioid-unresponsive cancer-related neuropathic pain
jRCTs051190097Active, not recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Randomised, double-blind trial in Neuralgia comparing Duloxetine Arm with Pregabalin Arm (2 arms). Primary endpoint: Worst pain intensity at Day 14. Started Feb 2020; status: active, not recruiting.
02
Drugs
duloxetinepregabalin
03
Conditions
Neuralgia
Beyond the preview
Go deeper on jRCTs051190097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051190097.